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Background: Northwestern Nicaragua has a high prevalence of chronic kidney disease (CKD) of unknown cause
among young adult men. In addition, frequent occurrence of urinary tract infections (UTI) among men and a
dysuria syndrome described by sugarcane workers as “chistata” are both reported. This study examines health
professionals´ perceptions regarding etiology of these conditions and their treatment approaches, including use of
potentially nephrotoxic medications.
Methods: Nineteen in-person semi-structured interviews were conducted in November 2010 among ten physicians
and nine pharmacists practicing in the region.
Results: Health professionals perceived CKD as a serious and increasing problem in the region, primarily affecting young
men working as manual laborers. All interviewees regarded occupational and environmental exposure to sun and heat,
and dehydration as critical factors associated with the occurrence of CKD. These factors were also considered to play a
role in the occurrence of chistata in the region. Health professionals indicated that reluctance among workers to hydrate
might be influenced by perceptions of water contamination. Symptoms often were treated with non-steroidal anti-
inflammatory drugs (NSAIDs), diuretics and antibiotics. Physicians acknowledged that the diagnosis of UTI usually was not
based on microbial culture and opined that the use of potentially nephrotoxic medications may be contributing to CKD.
Conclusions: Interviews provided evidence suggesting that medications such as diuretics, antibiotics and NSAIDs are
widely used and sold over the counter for symptoms that may be related to dehydration and volume depletion. These
factors, alone or in combination, may be possible contributors to kidney damage. Acute kidney damage coupled with
volume depletion and exposures including medications and infectious agents should be further evaluated as causal
factors for CKD in this region.Background
Chronic kidney disease (CKD) is a serious and increasing
global health problem. Treatment for its most severe form,
end stage renal disease, with dialysis or transplant is cur-
rently not available in many parts of the world [1,2]. Major
known risk factors for CKD include diabetes and hyperten-
sion [3,4]. However, in lower income countries CKD may
be associated with chronic glomerulonephritis and intersti-
tial nephritis, which are generally ascribed to infectious and
parasitic agents [5]. In Central America, case reports and* Correspondence: MLS@bu.edu
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distribution, and reproduction in any mediumgovernment statistics document high mortality due to
CKD, particularly among younger men and in certain re-
gions of the Pacific coast [6-8]. Community prevalence
studies in Nicaragua and El Salvador are consistent with
these mortality data and have attempted to assess associa-
tions with pharmaceutical, behavioral, environmental and
occupational exposures [9-15]. However, the causes of the
high prevalence of CKD remain unknown.
Our team has been working in northwestern Nicaragua
since 2009 as part of a mediation process (termed the
“Dialogue Table”) including the management of Nicaragua
Sugar Estates Limited (NSEL), a major sugar producer in
northwestern Nicaragua that operates the Ingenio San
Antonio located in the town of Chichigalpa, and theCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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group of approximately 2000 former NSEL workers and
community members who are affected by CKD. The Dia-
logue Table was established in 2008 after ASOCHIVIDA
filed a complaint with the Compliance Advisor Ombuds-
man (CAO), the independent office that handles com-
plaints from communities against the World Bank
Group’s private sector arm which had provided funding to
NSEL. CAO formed the Dialogue Table in response to the
complaint, and the participants determined that they
wanted an outside scientific group to make an independ-
ent assessment of the epidemic. Our team led by the
Boston University School of Public Health was selected by
Dialogue Table participants.
Our research occurred in stages, beginning with a “scop-
ing study” summarizing the available information on CKD
in the region, identifying data gaps, and recommending
research activities to address those gaps [16]. During the
process of conducting the scoping study we learned from
members of the Dialogue Table and from informal discus-
sions with area physicians of the frequent occurrence of a
set of symptoms referred to locally as “chistata,” character-
ized by painful urination and often accompanied by “kid-
ney” and/or back pain, and the common diagnosis of
urinary tract infections (UTIs) among young men. Our
final list of potential causes was extensive [16]. We identi-
fied several feasible activities that would provide more in-
formation to evaluate these hypotheses [16,17].
Among the subsequent research activities, we
conducted qualitative interviews in Chinandega and
Leon (regions with the highest CKD mortality rates in
Nicaragua) both with physicians who are likely to diag-
nose or treat chistata, UTI, and/or CKD and with retail
pharmacists who are likely to fill prescriptions or sell medi-
cations to treat these conditions. Medication use was on
our list of hypotheses because members of the Dialogue
Table reported that use of analgesics, and potentially
nephrotoxic antibiotics that would require prescriptions in
many higher income countries, were common in Nicaragua
and could be obtained without a prescription. Medications
are a common cause of acute kidney injury and may be
associated with CKD [18]. For example, non-steroidal anti-
inflammatory drugs (NSAIDs) are a frequent cause or
contributor to acute kidney failure in the setting of severe
volume depletion or other nephrotoxins. Aminoglycosides
(a class of broad spectrum antibiotics) also are common
causes of acute kidney failure, with risk factors including
preexisting kidney disease, concomitant nephrotoxic medi-
cation use, and dehydration/volume depletion.
Study aims
While there had been a great deal of media and activism
focused on CKD and potential causes in Nicaragua, we
did not know the general knowledge, opinion or practiceof physicians and pharmacists in the region. Our aims in
this study were to: (1) increase our understanding of
health professionals´ perceptions regarding CKD in the
region (characteristics of the affected population, causal
hypotheses, symptoms, diagnostic tools, treatment and
prognosis); (2) determine whether further study of the
relationship among hydration practices, diagnosis of
UTI/chistata and use of medications is warranted; and
(3) explore potential opportunities for public health in-
terventions related to the CKD epidemic aimed at physi-
cians and pharmacists. This was the first effort known of
by our team to engage physicians and pharmacists in
Nicaragua in a formal assessment of the CKD epidemic.
Methods
Recruitment and interviews were conducted in November
2010. In order to select interviewees, we acquired a list of
public or government health care institutions from the
Ministry of Health and a registry of pharmacies in
Chinandega and León. We also acquired a list of private
health institutions or clinics where CKD patients may seek
care from the Social Security System. Each of the two re-
gions (Chinandega and Leon) contained one main referral
hospital, 13 and 16 public health centers, 6 and 4 social se-
curity or private clinics, and 145 and 212 pharmacies, re-
spectively. We selected physicians from the health care
institutions in each region so as to achieve a diverse sam-
ple with regard to sex, location, type of institution, and
specialty of physician, and then selected pharmacies based
on proximity to the sampled health care facilities. We esti-
mated that 10 physicians and 10 pharmacists would be a
feasible number to interview given time and budget con-
straints, would be sufficient to reach data saturation (i.e.,
redundancy in results to the point where interviews are
not providing new information), and would enable us to
identify trends and themes in the data.
We prepared an interview guide that consisted of 34
and 24 open-ended questions asked of physicians and
pharmacists, respectively (available upon request).
Open-ended questions asked in qualitative studies are
typically designed to learn the opinion, beliefs, experi-
ence and reported behavior of the interviewee without
prescribing response options or leading interviewees to a
particular answer. We developed the interview guide
with our hypotheses in mind, to learn from interviewees
their opinion about the strength of various hypotheses
based on their experience, and also to learn from physi-
cians and pharmacists about their own hypotheses, if
any, regarding the causes of CKD in the region. We
began with broad questions such as, “What can you tell
me about CKD in Nicaragua?” following up with more
specific questions such as: “Do you think CKD is a prob-
lem in Nicaragua?”, “Has the number of cases you see
each year changed in the time you have been in




Women 6 (60) 8 (89)
Men 4 (40) 1 (11)
Region
Leon 5 (50) 5 (56)
Chinandega 5 (50) 4 (44)
Location
Rural 6 (60) 6 (67)
Urban 4 (40) 3 (33)
Health Institution
Health Center 7 (70) NA
Hospital/2nd level health center 3 (30) NA
Physician Specialty
General Practitioner 6 (60) NA
Nephrologist/Internal Medicine 4 (40) NA
Years of experience 19 (9–30) 10 (1–25)
Interview length (minutes) 41 (11) 18 (4)
Results are number (%) for all variables, except median (range) for years of
experience and mean (sd) for interview length. NA: Not Applicable.
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population?” For each major topic, we started with a
broad question, “What do you think are the causes of
CKD in Nicaragua?” and then followed up with specific
questions that might indicate their opinion of hypothe-
sized causes. Questions asked of both groups addressed
the following topics: 1) prevalence and causes of CKD in
Nicaragua; 2) population most affected; 3) beliefs regard-
ing dysuria-related symptoms, prevalence of UTI and
sexually transmitted infections; and 4) knowledge re-
garding indications and risks associated with use of po-
tentially nephrotoxic medications. Additionally we asked
physicians about standards and criteria for diagnosis and
treatment of CKD and the availability and cost of diag-
nostic tests and medications. Interviews included a series
of follow-up questions or probes to elicit additional in-
formation on these topics if not volunteered. A draft of
the physician interview guide was tested with a physician
in Nicaragua associated with our study team to deter-
mine if the length, organization and Spanish translation
were appropriate.
Interviews were conducted individually and in-person
by a native Spanish speaker (ORR). Informed consent
was obtained at the time of the interview. Ethics ap-
proval was obtained both from the Institutional Review
Board of Boston University Medical Campus and the
Nicaraguan Ministry of Health. All interviews were elec-
tronically recorded, transcribed and translated into Eng-
lish by a professional transcription agency and cross-
checked for accuracy by the interviewer. All identifiers
(i.e., names of individuals, locations and names of insti-
tutions) were removed from English and Spanish ver-
sions of the transcripts prior to analysis. To protect
anonymity, all research participants are referred to by a
masculine pronoun regardless of sex.
Interviews were analyzed using standard social science
methods for analyzing qualitative data [19]. An initial list
of 33 codes (words and phrases used to tag portions of
the transcript) was created based on the interview ques-
tions, which were based on existing hypotheses [20].
Coding the transcripts enables analysts to retrieve codes
and associated data and to assign values of frequency,
presence/absence and relationship with other codes [21].
For example, the code “CKDOCC” allowed us to tag and
retrieve all text, including positive and negative exam-
ples, in which the occupation of CKD patients is referred
to either in response to the question about the popula-
tions that are most affected, or in a different part of the
interview. Text associated with each code can then sub-
sequently be analyzed, and additional codes developed
(e.g., OCCAG, to tag more specific mentions of agricul-
tural occupation) [20]. Two analysts (MKS, ORR) separ-
ately coded the text and then together reviewed the
codes. After agreement was reached on coded text, eachanalyst prepared summaries of the findings and met again
to test agreement. The last step was to organize codes
under thematic or conceptual headings and to assign
meaning to the codes [20]. Specifically, we sought to
understand how potential causes of the CKD epidemic
identified in the interviews compared with our pre-
existing hypotheses, and how perception of these causes
might potentially inform future research activities.
Results
All physicians and pharmacists approached by our team
agreed to be interviewed, demonstrating a high level of
awareness and concern regarding the disease, societal ef-
fects and implications for their practice. We interviewed
ten physicians and nine pharmacists who were diverse
with regard to geographic areas and locations (Table 1).
Six of the nine pharmacists reported a degree in Pharmacy
and/or Chemistry, with three reporting no formal training.
The results of our analysis are organized by headings that
reflect key findings of physician and pharmacist opinions,
experiences and practices. (See Additional file 1 for further
quotes). Figure 1 demonstrates the relationships, with dif-
ferent degrees of certainty, identified by interviewees re-
garding several key causal hypotheses, beginning with the
relationship between occupational exposure to heat and
manual labor, followed by the occurrence of Chistata and
diagnosis of UTI, use of medications, and eventual CKD,
while including other potentially nephrotoxic exposures in
what is largely considered to be a multi-factorial disease.
Repeated AKI 
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Figure 1 Conceptual model of excess heat hypothesis.
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and increasing problem in Nicaragua
All interviewees stated that CKD is a serious problem.
With the exception of one pharmacist, all interviewees
were of the opinion that the number of CKD cases has
increased each year, although four physicians suggested
that this may be partially explained by improvements in
monitoring and diagnoses.
All physicians indicated that the observation of de-
creased kidney function over time would be the basis for
the CKD diagnosis. Seven of the ten physicians observed
that patients with CKD had no or very little proteinuria.
Six physicians relied on serum creatinine to classify a pa-
tient with CKD while four also calculated estimated glom-
erular filtration rate. Seven physicians indicated that, while
ideal, kidney ultrasounds require referral to a hospital or
private clinic and are usually not feasible. In terms of treat-
ment, seven of the ten physicians said they do not have
access to national or regional guidelines for the diagnosis
and treatment of CKD and therefore relied on guidelinesfor other chronic diseases (hypertension or diabetes), their
own familiarity with CKD, or, in one instance, an “ad hoc”
protocol developed by local physicians. Three physicians
who said they had access to CKD-specific diagnosis and
treatment guidelines referred to protocol of Nicaragua’s
Nephrology Association or the Ministry of Health, or inter-
national standards published by the National (USA) Kidney
Foundation’s Kidney Disease Outcomes Quality Initiative.
All physicians indicated that patient survival depends on
stage of CKD at diagnosis, self-care, and nutrition as well
as access to dialysis or transplant, neither of which are
widely available in Nicaragua.
CKD causes: strong sun, hard work, and. . . water?
All ten physicians and six of nine pharmacists described
men as the most affected population. More than half of the
physicians volunteered that the causes of the CKD epi-
demic did not include the traditional risk factors of diabetes
or hypertension. Four physicians suggested that, while
women experience CKD, the majority of cases in women
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population was most often described as under age 45.
Seven of the ten physicians identified agricultural
workers (fruit pickers and workers on banana, cotton,
melon, peanut, rice, and sugar plantations) as most af-
fected by CKD. Eight of nine pharmacists explicitly identi-
fied what they thought was an occupational association,
with one stating: “Those who are not diabetic are almost
all males who work in the fields.” Other non-agricultural
occupations mentioned included miners, construction
workers and bricklayers.
Nine physicians referred to exposures at work, with
seven identifying exposure to sun and heat as the major
occupational factor associated with CKD. All ten physi-
cians described many possible contributors to CKD, with
six using the term “multi-factorial.” Chemicals used in
agriculture were identified as a possible cause by half the
physicians, and three talked about contaminated drink-
ing water, with two referring specifically to heavy metals.
Water was the common denominator in eight of nine
pharmacist responses regarding the causes of CKD; how-
ever, there were two distinct perspectives on the role of
water. Four pharmacists thought that insufficient water
intake was the primary problem, while four other pharma-
cists believed that drinking contaminated water was the
problem. Three of the four pharmacists who thought
dehydration was the problem also thought it was not the
only cause, or else, as one said, “everyone would be dead.”
Another pharmacist summarized beliefs about causes:
“I think that [CKD] is from the dehydration they get
in the fields, their work is hard, hard, and they ruin
themselves taking diuretics and further draining their
body water.”
Other causes of CKD mentioned by more than one inter-
viewee (in order of frequency) were the use of nephrotoxic
medications, alcohol, and poor nutrition. Other possible
contributors mentioned included leptospira infection and
volcanic ash.
“Chistata” and UTI: physician perspectives on their
diagnosis and treatment, and associations with CKD
All physicians said that “chistata” is a colloquial term used
to characterize a constellation of symptoms including
“pain,” “burning” and the “urgent” need to urinate, with
chistata approximating the clinical term dysuria. Nine phy-
sicians opined that dehydration is a probable cause of
chistata, while eight also cited UTIs. There was disagree-
ment among physicians as to how closely infection was re-
lated to chistata, with some equating the two, and at least
one insisting, “they cannot just be considered synonymous.”
When queried further about UTI, four of the ten physi-
cians claimed to diagnose UTI based on the results of aurine culture. However, two of these physicians acknowl-
edged that they do not have the facilities to analyze a urine
culture and, as one stated, it would be “at the cost of the
patient.” Instead, these two along with five others admit to
diagnosing UTI based on a urine exam indicating the
presence of leukocytes, bacteriuria and/or nitrites via dip-
stick when available, under a microscope, or a combin-
ation of both practices. One physician suggested UTIs are
probably over diagnosed:
“What happens is that we have been doing a bad
management of the urinary tract infections. . . sometimes
we consider that the appearance of white blood cells,
leukocytes, in urine is enough. But it is not like that.”
When asked about the relationship among chistata,
UTI and CKD, seven physicians said that UTIs may be
associated with CKD. Five thought the connection had
to do with repeated, non-treated or inadequately treated
UTIs and regular use of broad spectrum antibiotics.
There was no agreement regarding the relationship of
nephrolithiasis with CKD. Four physicians said that stones
are not frequent, while six said they are very frequent.
Three physicians named kidney calculi as a possible cause
of chistata, with two associating them with “too concen-
trated urine” or “sandy urine” due to dehydration.
When asked how chistata is treated, seven physi-
cians said they recommend oral rehydration solutions,
and seven recommended urinary analgesics such as
phenazopyridine or the antibiotic nitrofurantoin. Five phy-
sicians specified that they would not treat chistata without
further tests. Antibiotics that they might then prescribe in-
cluded fluoroquinolones, amoxicillin, and penicillin, with
one physician naming aminoglycosides.
Treatment of UTIs included the same urinary analgesics
and antibiotics enumerated for chistata plus other beta-
lactam antibiotics and cephalosporins. One physician
stated that gentamicin should be used only in very select
cases, cautioning of its nephrotoxicity. When answering a
question regarding the uses of gentamicin later in the
interview, most physicians responded that it was reserved
for severe UTI or sepsis patients. Two noted its nephro-
toxicity, with one noting he sometimes had to use genta-
micin due to the unavailability of other medications.
Eight physicians acknowledged the possible nephro-
toxic effects of long-term intake of NSAIDs, with six
saying they would not prescribe them (or would restrict
their use) in CKD patients. However, two physicians said
NSAIDS are prescribed for back pain.
Pharmacist perceptions of UTI, Chistata, CKD and their
treatment
Pharmacists did not make the distinctions that physi-
cians did among the symptoms or conditions of low
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referred to CKD as an infection. Three said that UTI
and chistata are the first step, or “warning,” of CKD.
Three other pharmacists suggested that CKD results
from UTIs that were either not treated or treated
ineffectively.
When asked specifically about prescriptions filled for
CKD, eight of nine pharmacists named phenazopyridine
(not known to be nephrotoxic) in addition to antibiotics.
One pharmacist offered the following: “For kidney insuf-
ficiency, doctors from health centers here commonly
prescribe ampoules called gentamicin, trimethoprim-
sulfa. . .” This contradicts what the majority of physicians
indicated as per gentamicin prescription. For the most
part, however, pharmacists described giving the same
medications as the physicians for treatment of chistata
and UTIs plus some antispasmodic drugs and NSAIDs.
Pharmacists did not mention oral rehydration solutions.
Pharmacists’ responses revealed a range of opinions
and practices regarding their role in the diagnosis and
treatment process. On one end of the spectrum are
those who would not prescribe anything until a patient
is diagnosed by a physician, and on the other end are
those willing to provide treatment directly. However,
most said they would first recommend the patient obtain
a urinalysis and have it interpreted by a physician. In
some cases pharmacists offered to interpret lab results.
Four pharmacists described the practice of selling antibi-
otics without a doctor’s prescription or a formal diagno-
sis. One pharmacist described the pressure to sell
antibiotics over the counter with no diagnosis: “They’ll
say, ‘Why can’t you give me one directly? Why do I have
to go and spend money to get an exam?’ So I recom-
mend them cefadroxil.”
Three pharmacists said that they would first recom-
mend diuretics: “Furosemide is the most common, I sell
it every day.” Recognizing that diuretics could further
tax the kidney, another pharmacist explained:
“When I sell it, I tell people to drink plenty of fluids.
But at the end, that is the decision of people, right?
But I let them know that [the medication] can damage
the kidney.”
Several physicians opined that pharmacists are enab-
ling patients to self-medicate and selling potentially
harmful medication: “The problem is that NSAIDs and
gentamicin are sold in the markets of cities like candies”
and “agricultural workers with back pain get shots of
gentamicin by vendors in stores.” Taking diuretics for
chistata was also described by two physicians:
“. . . these patients that normally have chistata are
dehydrated most of the time, so what they do is take afurosemide to get rid of [chistata]. And later, they arrive
with cramps, more dehydrated, and it becomes chaos.”
Discussion
Interviews of physicians and pharmacists in Western
Nicaragua were consistent with the existence of an epi-
demic of CKD, describing characteristics similar to those
noted in the prevalence studies conducted in the region
[10-13,22]. These include CKD being more frequent
among men, starting in young adulthood, and associated
with mainly agricultural work but also occurring in miners
and construction workers. The sentiment that diabetes
and hypertension cannot explain the CKD epidemic in
Nicaragua was also expressed in the interviews. If this sen-
timent is based on empirical observations of physicians
and pharmacists, these findings provide additional verifi-
cation of the findings of local studies. The primary contri-
bution of this study, however, is highlighting medication
usage patterns described by physicians and pharmacists
that have not previously been well characterized in cohort
studies and government data, and which may lead to in-
creased risk of CKD among younger men in this region.
Interviews indicate that patients with CKD, or at high
risk for CKD, may be receiving nephrotoxic drugs for
the syndromes of chistata and UTI. In particular,
aminoglycoside antibiotics and chronic use of NSAIDs
are associated with acute kidney injury (AKI) in a dose-
and duration-dependent manner [23-25]. This associ-
ation is particularly notable in the setting of volume de-
pletion, which may be further aggravated due to the use
of diuretics. Reports that attempt to quantify regional
NSAIDs use vary widely, with self-reported use ranging
from 10 to 75% of study populations [11,12,14].
Despite the media attention given to the potential role
of agrichemicals in causing CKD, physicians and pharma-
cists were much more likely to cite exposure to heat,
physical work and dehydration as key factors responsible
for CKD; a common combination of exposures among
men in this region and in Central America [17,22,26,27].
This opinion is consistent with local and regional studies,
which find that CKD appears more common among occu-
pations where strenuous work undertaken at high ambient
temperatures is typical [9-13,28,29]. Although not a recog-
nized cause of CKD, heat stress is associated with volume
depletion and may also be associated with muscle damage
(rhabdomyolysis), both of which may predispose individ-
uals to AKI, particularly in the presence of nephrotoxic
medications [26,27,30,31]. Critically, there is a growing
body of literature that suggests that AKI, even if mild or if
the serum creatinine recovers to baseline, may result in re-
sidual structural damage and ultimately progress to clinic-
ally recognized CKD [32-36] (See Figure 1).
Our interviews provide inconsistent yet important in-
formation regarding the perceived role of drinking water
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drinking enough water leads to CKD, and the other half
believing that CKD may be caused by drinking contami-
nated water. These beliefs, taken at surface value, would
result in contradictory recommendations to area resi-
dents and workers. However, it is too early to say which
view is correct and the truth may lie somewhere in be-
tween. Even if drinking water contaminants are not
known to directly cause CKD, it cannot be concluded
that drinking water quality is acceptable in various areas.
Additionally, the emphasis of interviewees was that de-
hydration is due in part to perceptions of water and
water consumption practices. The question remains, is
hydration in general recommended or water consump-
tion specifically? If lacking clean water, should workers
and the general public be advised to hydrate with soda
or fruit juices? What are the risks and benefits of hydrat-
ing with these high-sugar fluids compared with unclean
water? To the extent that the contradictory views of
pharmacists may represent those in the broader commu-
nity, further examination of these questions would be
beneficial before public health professionals design inter-
ventions with messages simply exhorting people to drink
more water.
According to both physicians and pharmacists, UTI is
one of the main causes of chistata. However, in medical
practice elsewhere UTI is very uncommon among youn-
ger men with the rare cases typically associated with con-
genital urinary tract abnormalities or obstruction such as
from nephrolithiasis. Urine cultures analyzed by our group
from 47 male workers whose urine dipstick results were
positive for leukocyte esterase or who had complained of
dysuria within the past 24 hours were all negative for bac-
terial growth [37], supporting the impression of some phy-
sicians that UTI is likely over-diagnosed.
Exposures to agrichemicals, heavy metals, alcohol con-
sumption and infectious agents were also mentioned in
physician and pharmacist interviews and are the focus of
additional causal hypotheses in the region [11-14]. In
particular, infection by leptospirosis, although mentioned
by only one interviewee, is considered an occupational
hazard for people who work outdoors, including sugar-
cane field workers, and a high seroprevalence of lepto-
spirosis has been described in northwestern Nicaragua
[38,39]. Manifestations of leptospirosis range from sub-
clinical infection to severe disease accompanied by acute
kidney failure. To date, there has been little research re-
garding the potential for leptospirosis infection to cause
chronic tubular dysfunction or CKD in the absence of
severe acute illness [40-42].
Limitations of our study include the inability to deter-
mine the truthfulness and accuracy of interviewee re-
sponses, and the small number of physicians and
pharmacists interviewed. Qualitative studies are rarelydesigned to have statistically representative samples of
the population, but for several of our questions we could
have learned more about the general practice among
physicians in particular if we had been able to conduct
more interviews and achieved a higher degree of redun-
dancy in the responses. However, these interviews have
highlighted several potential contributors to CKD in
Nicaragua including heat stress and use of potential
nephrotoxic medications, supporting the plausibility of a
multi-factorial cause of CKD. These findings also pro-
vide impetus for future cohort studies designed to exam-
ine such exposures and diagnoses.
Recommendations
Many features of CKD in Central America require fur-
ther elucidation. These include identifying the true cause
of “chistata” and UTI-like symptoms, evaluating poten-
tial associations among heat stress, UTI diagnosis and
nephrotoxic medication use, evaluating the role of sys-
temic infectious diseases, and assessing the potential
contribution of all of these factors to the development of
CKD. However, until such time, the possible association
between the occupational exposure to heat and the use
of potentially nephrotoxic medications may be a benefi-
cial focus of regional preventive health programs [43],
including at the workplace, at the community level, and
in health care settings. Surveillance systems of worker
symptoms of heat exposure and workload, together with
hydration practices, could be consolidated by governmental
agencies, periodically assessed for lessons learned/best prac-
tices, and shared with employers. Similarly, there have been
several assessments of water quality in specific areas. These
assessments could be compiled with a similar analysis,
identifying and addressing data gaps with further testing, so
(a) public health professionals can make scientifically-based
recommendations regarding consumption of water, and (b)
local health agencies could come up with rapid and inex-
pensive processes to check for local variability (e.g., arsenic
may be an issue in some areas, not in others). Overall, re-
search into current hydration practices and promoters, and
obstacles to greater hydration, could help shape public
health recommendations.
Common self-medication reported by pharmacists and
physicians of widespread (across the community and
particularly workers) dysuria related symptoms with di-
uretics, NSAIDs and antibiotics could be the target of
greater oversight and health protection measures from
government agencies. The contradiction between phar-
macists reporting that physicians prescribe gentamicin,
and physicians reporting otherwise, could also be ex-
plored via observations at pharmacies where prescrip-
tions are filled. Finally, we recommend increased and
targeted education for pharmacists and physicians on
the diagnosis and treatment of heat exposure symptoms,
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pharmacists when confronted with patients who demand
medications that may be nephrotoxic.
Conclusions
High mortality has been documented due to CKD among
young adult men in Northwest Nicaragua, and specific
areas of Central America including regions of El Salvador
and Costa Rica, the cause of which remains unknown.
This study identifies perceived causes of the CKD epi-
demic in Nicaragua by physicians and pharmacists work-
ing on the front line. Our analysis articulates perceptions
of physicians and pharmacists that heat stress and subse-
quent volume depletion experienced by manual laborers
plays a role in the frequent occurrence of dysuria-like
symptoms, which are often treated with non-steroidal
anti-inflammatory drugs, diuretics and antibiotics that
may be further nephrotoxic.
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